Abstract
Biofilms lead to approximately 65% of infections, and these infections are hard to treat. Thus, it is crucial to identify effective antibiofilm agents with low cytotoxicity. Peptides with antibiofilm activity have been regarded as promising solutions, and peptides with MBICs (minimal biofilm inhibitory concentrations) that are lower than their minimal inhibitory concentration (MICs) (minimal inhibitory concentrations) are appealing. Therefore, we systematically summarized and classified previously reported peptides with antibiofilm activity. A total of 51 peptides with antibiofilm activity were classified into 14 categories. The MICs and MBICs of these fourteen representative peptides, one selected from each category, were compared against the Gram-positive bacterium Streptococcus mutans, the Gram-negative bacterium Pseudomonas aeruginosa, and the fungus Candida albicans. Six representative peptides (C5-pleurocidin, C6-Pac-525, C9-protegrin-1, C11-TetraF2W-RR, C13-WLBU2, and C14-melittin) showed antibiofilm activity against both bacteria and fungi, and among these 6 representative peptides, 4 peptides (C9-protegrin-1, C11-TetraF2W-RR, C13-WLBU2, and C14-melittin) could prevent biofilm formation with lower MBIC values than their MICs. CLSM (confocal laser scanning microscopy), SEM (scanning electron microscopy), and TEM (transmission electron microscopy) were further used to observe the morphologies of the biofilms after treatment with the peptides. Among the above 4 peptides, WLBU2 and melittin sparsely scattered the biofilms without destroying the bacteria. In conclusion, the currently reported peptides with antibiofilm activity are limited in number, but peptides with lower MBICs than MICs exist as promising candidates against biofilm-related infections and need further study.
Key points
• Antibiofilm peptides could inhibit biofilm formation with MBICs that are lower than MICs.
• The mechanism of antibiofilm peptides is not only due to antimicrobial activity.
Similar content being viewed by others
Data availability
The datasets generated for this study are available from the corresponding author on reasonable request.
References
Ansari JM, Abraham NM, Massaro J, Murphy K, Smith-Carpenter J, Fikrig E (2017) Anti-biofilm activity of a self-aggregating peptide against Streptococcus mutans. Front Microbiol 8(MAR) doi:https://doi.org/10.3389/fmicb.2017.00488
Bardbari AM, Arabestani MR, Karami M, Keramat F, Aghazadeh H, Alikhani MY, Bagheri KP (2018) Highly synergistic activity of melittin with imipenem and colistin in biofilm inhibition against multidrug-resistant strong biofilm producer strains of Acinetobacter baumannii. Eur J Clin Microbiol Infect Dis 37(3):443–454. https://doi.org/10.1007/s10096-018-3189-7
Bowdish DM, Davidson DJ, Hancock RE (2005) A re-evaluation of the role of host defence peptides in mammalian immunity. Curr Protein Pept Sci 6(1):35–51. https://doi.org/10.2174/1389203053027494
Chandra J, Kuhn DM, Mukherjee PK, Hoyer LL, McCormick T, Ghannoum MA (2001) Biofilm formation by the fungal pathogen Candida albicans: development, architecture, and drug resistance. J Bacteriol 183(18):5385–5394. https://doi.org/10.1128/jb.183.18.5385-5394.2001
Costerton JW, Stewart PS, Greenberg EP (1999) Bacterial biofilms: a common cause of persistent infections. Science 284(5418):1318–1322. https://doi.org/10.1126/science.284.5418.1318
Dawson RM, Liu CQ (2008) Properties and applications of antimicrobial peptides in biodefense against biological warfare threat agents. Crit Rev Microbiol 34(2):89–107. https://doi.org/10.1080/10408410802143808
de la Fuente-Nunez C, Korolik V, Bains M, Nguyen U, Breidenstein EB, Horsman S, Lewenza S, Burrows L, Hancock RE (2012) Inhibition of bacterial biofilm formation and swarming motility by a small synthetic cationic peptide. Antimicrob Agents Chemother 56(5):2696–2704. https://doi.org/10.1128/AAC.00064-12
de la Fuente-Nunez C, Reffuveille F, Fernandez L, Hancock RE (2013) Bacterial biofilm development as a multicellular adaptation: antibiotic resistance and new therapeutic strategies. Curr Opin Microbiol 16(5):580–589. https://doi.org/10.1016/j.mib.2013.06.013
de la Fuente-Nunez C, Reffuveille F, Haney EF, Straus SK, Hancock RE (2014) Broad-spectrum anti-biofilm peptide that targets a cellular stress response. PLoS Pathog 10(5):e1004152. https://doi.org/10.1371/journal.ppat.1004152
de la Fuente-Nunez C, Cardoso MH, de Souza CE, Franco OL, Hancock RE (2016) Synthetic antibiofilm peptides. Biochim Biophys Acta 1858(5):1061–1069. https://doi.org/10.1016/j.bbamem.2015.12.015
Di Somma A, Moretta A, Cane C, Cirillo A, Duilio A (2020) Antimicrobial and antibiofilm peptides. Biomolecules 10(4). https://doi.org/10.3390/biom10040652
Dostert M, Belanger CR, Hancock REW (2019) Design and assessment of anti-biofilm peptides: steps toward clinical application. J Innate Immun 11(3):193–204. https://doi.org/10.1159/000491497
Hall-Stoodley L, Costerton JW, Stoodley P (2004) Bacterial biofilms: from the natural environment to infectious diseases. Nat Rev Microbiol 2(2):95–108. https://doi.org/10.1038/nrmicro821
Haney EF, Brito-Sanchez Y, Trimble MJ, Mansour SC, Cherkasov A, Hancock REW (2018) Computer-aided discovery of peptides that specifically attack bacterial biofilms. Sci Rep 8(1):1871. https://doi.org/10.1038/s41598-018-19669-4
Hoiby N, Ciofu O, Johansen HK, Song ZJ, Moser C, Jensen PO, Molin S, Givskov M, Tolker-Nielsen T, Bjarnsholt T (2011) The clinical impact of bacterial biofilms. Int J Oral Sci 3(2):55–65. https://doi.org/10.4248/ijos11026
Hoskin DW, Ramamoorthy A (2008) Studies on anticancer activities of antimicrobial peptides. Biochim Biophys Acta 1778(2):357–375. https://doi.org/10.1016/j.bbamem.2007.11.008
Jang H, Arce FT, Mustata M, Ramachandran S, Capone R, Nussinov R, Lal R (2011) Antimicrobial protegrin-1 forms amyloid-like fibrils with rapid kinetics suggesting a functional link. Biophys J 100(7):1775–1783. https://doi.org/10.1016/j.bpj.2011.01.072
Kokryakov VN, Harwig SS, Panyutich EA, Shevchenko AA, Aleshina GM, Shamova OV, Korneva HA, Lehrer RI (1993) Protegrins: leukocyte antimicrobial peptides that combine features of corticostatic defensins and tachyplesins. FEBS Lett 327(2):231–236. https://doi.org/10.1016/0014-5793(93)80175-t
Li B, Li X, Lin H, Zhou Y (2018) Curcumin as a promising antibacterial agent: effects on metabolism and biofilm formation in S. mutans. Biomed Research International(4508709) doi:https://doi.org/10.1155/2018/4508709
Lin Q, Deslouches B, Montelaro RC, Di YP (2018) Prevention of ESKAPE pathogen biofilm formation by antimicrobial peptides WLBU2 and LL37. Int J Antimicrob Agents 52(5):667–672. https://doi.org/10.1016/j.ijantimicag.2018.04.019
Mah TF, O’Toole GA (2001) Mechanisms of biofilm resistance to antimicrobial agents. Trends Microbiol 9(1):34–39. https://doi.org/10.1016/s0966-842x(00)01913-2
Mishra B, Lushnikova T, Golla RM, Wang X, Wang G (2017) Design and surface immobilization of short anti-biofilm peptides. Acta Biomater 49:316–328. https://doi.org/10.1016/j.actbio.2016.11.061
Moskowitz SM, Foster JM, Emerson J, Burns JL (2004) Clinically feasible biofilm susceptibility assay for isolates of Pseudomonas aeruginosa from patients with cystic fibrosis. J Clin Microbiol 42(5):1915–1922. https://doi.org/10.1128/jcm.42.5.1915-1922.2004
Overhage J, Campisano A, Bains M, Torfs EC, Rehm BH, Hancock RE (2008) Human host defense peptide LL-37 prevents bacterial biofilm formation. Infect Immun 76(9):4176–4182. https://doi.org/10.1128/iai.00318-08
Raheem N, Straus SK (2019) Mechanisms of action for antimicrobial peptides with antibacterial and antibiofilm functions. Front Microbiol 10:2866. https://doi.org/10.3389/fmicb.2019.02866
Ryder MP, Wu X, McKelvey GR, McGuire J, Schilke KF (2014) Binding interactions of bacterial lipopolysaccharide and the cationic amphiphilic peptides polymyxin B and WLBU2. Colloids Surf B Biointerfaces 120:81–87. https://doi.org/10.1016/j.colsurfb.2014.05.004
Sani MA, Separovic F (2016) How membrane-active peptides get into lipid membranes. Acc Chem Res 49(6):1130–1138. https://doi.org/10.1021/acs.accounts.6b00074
Wiegand I, Hilpert K, Hancock RE (2008) Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances. Nat Protoc 3(2):163–175. https://doi.org/10.1038/nprot.2007.521
Yong YY, Dykes G, Lee SM, Choo WS (2019) Biofilm inhibiting activity of betacyanins from red pitahaya (Hylocereus polyrhizus) and red spinach (Amaranthus dubius) against Staphylococcus aureus and Pseudomonas aeruginosa biofilms. J Appl Microbiol 126(1):68–78. https://doi.org/10.1111/jam.14091
Zasloff M (2002) Antimicrobial peptides of multicellular organisms. Nature 415(6870):389–395. https://doi.org/10.1038/415389a
Contributions
L.H.C and C.D.R conceived and designed research. L.J conducted experiments and analyzed data. L.J and C.D.R systematically reviewed literature and wrote the manuscript. L.H.C revised the manuscript and provided useful suggestions. All authors read and approved the manuscript.
Funding
This work was supported by the National Natural Science Foundation of China (no. 81970928), Guangdong Basic and Applied Basic Research Foundation (no. 2019A1515110847), and Fundamental Research Funds for the Central Universities (no. 20ykpy74).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical statement
This article does not contain any studies with human participants or animals performed by any of the authors.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
ESM 1
(PDF 400 kb)
Rights and permissions
About this article
Cite this article
Li, J., Chen, D. & Lin, H. Antibiofilm peptides as a promising strategy: comparative research. Appl Microbiol Biotechnol 105, 1647–1656 (2021). https://doi.org/10.1007/s00253-021-11103-6
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00253-021-11103-6